Simigon Ltd
LSE:SIM
Simigon Ltd
LSE:SIM
Price:
13
GBX
Market Closed
Market Cap:
£6.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Simigon Ltd
LSE:SIM
|
IL |
|
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
|
CN |
|
D
|
Destek Finans Faktoring AS
IST:DSTKF.E
|
TR |
|
T
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
|
CN |
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
CN |
|
L
|
La Doria SpA
F:2DO
|
IT |
|
Sanken Electric Co Ltd
OTC:SANJF
|
JP |
|
Zhengzhou Qianweiyangchu Food Co Ltd
SZSE:001215
|
CN |
|
K
|
Kamux Oyj
OMXH:KAMUX
|
FI |
|
C
|
China CAMC Engineering Co Ltd
SZSE:002051
|
CN |
|
Shenzhen Rapoo Technology Co Ltd
SZSE:002577
|
CN |
|
Centum Electronics Ltd
NSE:CENTUM
|
IN |
|
Bioera SpA
MIL:BIE
|
IT |
|
E
|
Empower India Ltd
BSE:504351
|
IN |
|
Aisin Corp
TSE:7259
|
JP |
Balance Sheet
Balance Sheet Decomposition
Simigon Ltd
Simigon Ltd
Balance Sheet Decomposition is not available for
Simigon Ltd
Simigon Ltd
Balance Sheet
Simigon Ltd
Simigon Ltd
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
4
|
7
|
8
|
6
|
6
|
5
|
5
|
3
|
3
|
1
|
|
| Cash Equivalents |
4
|
7
|
8
|
6
|
6
|
5
|
5
|
3
|
3
|
1
|
|
| Short-Term Investments |
1
|
1
|
1
|
3
|
2
|
3
|
3
|
3
|
3
|
4
|
|
| Total Receivables |
2
|
1
|
0
|
1
|
4
|
3
|
2
|
3
|
1
|
1
|
|
| Accounts Receivables |
1
|
1
|
0
|
1
|
4
|
3
|
2
|
3
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
6
|
8
|
9
|
10
|
11
|
11
|
10
|
9
|
8
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| Total Assets |
8
N/A
|
9
+18%
|
11
+16%
|
12
+9%
|
13
+11%
|
13
+0%
|
12
-9%
|
11
-9%
|
10
-11%
|
7
-22%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
2
N/A
|
3
+30%
|
3
+15%
|
3
-7%
|
2
-14%
|
2
-6%
|
2
-6%
|
2
-1%
|
3
+15%
|
3
0%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
10
|
9
|
8
|
6
|
6
|
7
|
8
|
10
|
12
|
|
| Additional Paid In Capital |
16
|
16
|
16
|
16
|
17
|
17
|
17
|
17
|
17
|
17
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
7
+14%
|
8
+16%
|
9
+16%
|
10
+19%
|
11
+2%
|
10
-10%
|
8
-11%
|
7
-17%
|
5
-30%
|
|
| Total Liabilities & Equity |
8
N/A
|
9
+18%
|
11
+16%
|
12
+9%
|
13
+11%
|
13
+0%
|
12
-9%
|
11
-9%
|
10
-11%
|
7
-22%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
44
|
47
|
47
|
50
|
51
|
51
|
51
|
51
|
51
|
51
|
|
Switch to:
Switch to:
See Also
Discover More
